New England Biolabs will present new multiomic cell-free DNA and RNA analysis workflows, including enzymatic methylation profiling, at AMP 2026, with details on integrated protocols for molecular diagnostics.
BBI Solutions partnered with BioAgilytix to streamline the bioanalytical testing process for pharmaceutical and biopharmaceutical developers.
One lab that participated in NILA's survey reports having enough reagent to process 500 tests per day, yet their covid-19 testing capacity is at least 3,000 tests per day.
The highly specific and high-affinity antibodies are suitable for bioanalytical and patient drug level monitoring assays for the immune checkpoint inhibitor ipilimumab.
Read More
Antibodies targeting various snake and spider toxins are now commercially available in newly engineered formats.
Read More
Pico-Surf is a high-performing surfactant for use in a wide range of microfluidic application workflows
Read MoreThe new recombinant SARS-CoV-2 nucleocapsid protein is for covid-19 diagnostic test manufacturers, vaccine developers, and researchers globally.
Read More
Sustainable harvesting of limulus amebocyte lysate could save hundreds of thousands of horseshoe crabs per year, while offering life-saving clinical uses for humans.
Read More
The kit is particularly suitable for total nucleic acid extraction for detecting SARS-CoV-2, the virus that causes covid-19.
Read More
In response to the covid-19 pandemic, FDA has developed quality-controlled reference sequence data for the SARS-CoV-2 reference strain for the United States.
Read MoreThe new brand will be rolled out throughout 2020 through the company’s website and marketing communications, as well as at each of its four locations.
Read More
The newly developed recombinant antigens derived specifically from COVID-19 are intended for use in infectious disease research, and assay and vaccine development.
Read More
The partners’ cartridge-based instrument offers a novel and disruptive analysis and monoclonality assurance system for drug discovery and development.
Read More
BBI Solutions has announced the launch of new antibodies, including inflammatory, fertility, and infectious disease markers.
Read More
Three new standardized, preformulated DuraClone RE kits deliver high sensitivity to help study rare cell populations.
Read More
The suite of reagents from Ortho Clinical Diagnostics is used to determine the status of a designated antigen on human red blood cells.
Read More
ViroStat has released a set of mouse monoclonal antibodies to E. histolytica.
Read More
This month’s issue features hematology, blood banking, and organ transplantation products from such companies as Abbott, Advanced Instruments, Helmer Scientific, and Ortho Clinical Diagnostics.
Read More